Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsOther Accumulated ExpensesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Arcadia Biosciences (RKDA) Intangibles (2020 - 2025)

Arcadia Biosciences filings provide 6 years of Intangibles readings, the most recent being $39000.0 for Q4 2025.

  • On a quarterly basis, Intangibles changed 0.0% to $39000.0 in Q4 2025 year-over-year; TTM through Dec 2025 was $39000.0, a 0.0% change, with the full-year FY2025 number at $39000.0, changed 0.0% from a year prior.
  • Intangibles hit $39000.0 in Q4 2025 for Arcadia Biosciences, roughly flat from $39000.0 in the prior quarter.
  • In the past five years, Intangibles ranged from a high of $4.1 million in Q2 2021 to a low of $39000.0 in Q4 2023.
  • Median Intangibles over the past 5 years was $40000.0 (2022), compared with a mean of $536050.0.
  • Biggest five-year swings in Intangibles: skyrocketed 876.25% in 2021 and later tumbled 92.67% in 2023.
  • Arcadia Biosciences' Intangibles stood at $484000.0 in 2021, then crashed by 91.74% to $40000.0 in 2022, then fell by 2.5% to $39000.0 in 2023, then changed by 0.0% to $39000.0 in 2024, then changed by 0.0% to $39000.0 in 2025.
  • The last three reported values for Intangibles were $39000.0 (Q4 2025), $39000.0 (Q3 2025), and $39000.0 (Q2 2025) per Business Quant data.